CN Patent

CN116763898A — 一种蛋白酶抑制剂化合物在制备猫冠状病毒感染药物中的用途

Assigned to Beijing Kexiang Zhongsheng Pharmaceutical Technology Co ltd · Expires 2023-09-19 · 3y expired

What this patent protects

本发明公开一种蛋白酶抑制剂化合物及其药物物在制备猫传染性腹膜炎药物中的应用，本发明提供的化合物具有症状缓率高、症状缓解快、显著降低致死率、复发率低，抗FIPV病毒活性好、选择性高、白球比恢复正常水平时间短、治疗指数高、药效持久等优点。

USPTO Abstract

本发明公开一种蛋白酶抑制剂化合物及其药物物在制备猫传染性腹膜炎药物中的应用，本发明提供的化合物具有症状缓率高、症状缓解快、显著降低致死率、复发率低，抗FIPV病毒活性好、选择性高、白球比恢复正常水平时间短、治疗指数高、药效持久等优点。

Drugs covered by this patent

Patent Metadata

Patent number
CN116763898A
Jurisdiction
CN
Classification
—
Expires
2023-09-19
Drug substance claim
No
Drug product claim
No
Assignee
Beijing Kexiang Zhongsheng Pharmaceutical Technology Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.